Ilknur Nizam
Overview
Explore the profile of Ilknur Nizam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gocer M, Iltar U, Aykas F, Aslan V, Nizam I, Celik M, et al.
Acta Haematol
. 2019 Jun;
143(2):176-180.
PMID: 31167181
The vast majority of cases of thrombotic thrombocytopenic purpura (TTP) are the result of acquired antibodies which inhibit the activity of the ADAMTS13 enzyme. Acquired TTP is more frequently seen...
2.
Koroglu M, Erkurt M, Kuku I, Kaya E, Berber I, Nizam I, et al.
Med Sci Monit
. 2016 Apr;
22:1329-33.
PMID: 27097101
BACKGROUND Preventive interventions save lives during the process of chemotherapy for hematologic malignancies, when a hematology laboratory can ensure accurate results. The use of a pneumatic tube system (PTS) is...
3.
Berber I, Erkurt M, Kuku I, Kaya E, Bag H, Nizam I, et al.
Transfus Apher Sci
. 2016 Jan;
54(1):48-52.
PMID: 26809684
This study aimed to evaluate the efficiency of DHAP regimen plus filgrastim for mobilization of stem cells in patients with recurrent and/or refractory lymphoma. Thirty-four patients who took DHAP as...
4.
Berber I, Erkurt M, Nizam I, Koroglu M, Kaya E, Kuku I, et al.
Int J Clin Exp Med
. 2015 Dec;
8(9):16308-14.
PMID: 26629149
High-dose chemotherapy (HDC) applied together with autologous stem cell transplantation (ASCT) is a commonly used treatment modality in patients with malignant lymphoma. At present, there is a limited number of...
5.
Berber I, Erkurt M, Kuku I, Kaya E, Bag H, Nizam I, et al.
J Clin Apher
. 2015 May;
31(1):53-8.
PMID: 26011305
Aim: Leukapheresis is an invasive treatment modality used for hyperleukocytosis. Various drugs and fluids are used during the leukapheresis. Aging itself and associated factors such as increased comorbidity, decreased tolerance...
6.
Berber I, Kuku I, Erkurt M, Kaya E, Bag H, Nizam I, et al.
Transfus Apher Sci
. 2015 Apr;
53(2):185-90.
PMID: 25843763
Hyperleukocytosis is defined as WBC count above 100,000/mm(3) in peripheral blood. Increased WBC count leads to leukocyte aggregation, increased blood viscosity, and consequently results in stasis in small blood vessels....
7.
Erkurt M, Berber I, Berktas H, Kuku I, Kaya E, Koroglu M, et al.
Transfus Apher Sci
. 2015 Jan;
52(2):194-8.
PMID: 25595543
HELLP syndrome, which can affect multiple organ systems and cause maternal and fetal mortality, is a serious complication of pregnancy characterized by microangiopathic hemolytic anemia, elevation of liver enzymes, and...
8.
Korkmaz S, Dal M, Berber I, Goren Sahin D, Dogu M, Ayyildiz O, et al.
Geriatr Gerontol Int
. 2014 Sep;
15(6):729-35.
PMID: 25257190
Aims: We aimed to investigate whether older age leads to limitations in the starting dose of imatinib in daily treatment of chronic myeloid leukemia, and to determine the compliance of...
9.
Berber I, Erkurt M, Kuku I, Kaya E, Unlu S, Ertem K, et al.
Transfus Apher Sci
. 2014 Aug;
51(1):73-6.
PMID: 25113918
Thrombotic thrombocytopenic purpura is an acute syndrome with abnormalities in multiple organ systems, which becomes manifest with microangiopathic hemolytic anemia and thrombocytopenia. The hereditary or acquired deficiency of ADAMTS-13 activity...
10.
Berber I, Erkurt M, Kuku I, Kaya E, Koroglu M, Nizam I, et al.
Case Rep Hematol
. 2014 Apr;
2014:249195.
PMID: 24707413
Objective. The aim of this paper is to report the case of a patient diagnosed with Hermansky-Pudlak syndrome, as a result of bleeding diathesis. Clinical Presentation and Intervention. A 23-year-old...